AS

Anar Swapnil Shah

Active Director Director DIN 06895297
DIN 06895297 First appointment Jul 2014 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 9 active board seats
Past companies 4 historical roles
Total affiliations 13 Since Jul 2014
Shareholding value •••• Premium profile

About Anar Swapnil Shah

Data last updated:

Anar Swapnil Shah is a Director at Remus Pharmaceuticals Limited (since 2020), Designated Partner at Espee Therapeutics Llp (since 2016) and Director at Renosen Pharmaceuticals Private Limited (since 2019), and holds 6 more current directorships. The companies operate in Trading, Pharma and Business Outsourcing. The 4 current companies with reported revenue have a combined latest revenue of ₹647 Cr; the largest is Remus Pharmaceuticals Limited at ₹625 Cr (FY 2025). Earlier, Anar Swapnil Shah was a Designated Partner at Fifth Gear Fitness Llp (2015–2024) and Director at Senores Pharmaceuticals Limited (2017–2023) and 2 more.

DIN 06895297
Primary Designation Director
Industry Trading
First Appointment 17 Jul 2014
Oldest Company Age 14 yrs
Largest company Remus Pharmaceuticals Limited · ₹625 Cr (FY 2025)
Combined revenue ₹647 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Remus Pharmaceuticals Limited L24232GJ2015PLC084536
Director30 Dec 20202015₹625 Cr (FY 2025)Active
Designated Partner25 Nov 20162016₹13.65 Cr (FY 2021)Active
Director22 May 20192019₹7.36 Cr (FY 2025)Active
Designated Partner03 May 20192019₹45 Lakh (FY 2022)Active
Senores Foundation U88900GJ2025NPL169742
Director25 Nov 20252025Active
Senores Biologics Private Limited U21001GJ2025PTC165703
Director31 Jul 20252025Active
Director24 Jul 20252025Active
Relius Lifesciences Private Limited U24299GJ2016PTC094454
Director30 Jul 20202016Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner08 Jul 20152015Active
Senores Pharmaceuticals Limited L24290GJ2017PLC100263
Director26 Dec 20172017₹418 Cr (FY 2025)Active
Designated Partner13 Aug 20182018Strike Off
Additional Director17 Jul 20142012Converted To Llp

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Espee Therapeutics Llp
Aelius Projects Llp
Sumer Enterprises Llp
Healthy Life Nutraceuticals Private Limited
Premium access

Shareholding and investment profile for Anar Swapnil Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anar Swapnil Shah

Anar Swapnil Shah currently holds 9 directorships: Remus Pharmaceuticals Limited (Director, since 30 Dec 2020, revenue ₹625 Cr (FY 2025)); Espee Therapeutics Llp (Designated Partner, since 25 Nov 2016, revenue ₹13.65 Cr (FY 2021)); Renosen Pharmaceuticals Private Limited (Director, since 22 May 2019, revenue ₹7.36 Cr (FY 2025)); Aelius Projects Llp (Designated Partner, since 03 May 2019, revenue ₹45 Lakh (FY 2022)); Senores Foundation (Director, since 25 Nov 2025); and 4 more.

Anar Swapnil Shah was first appointed on 17 Jul 2014 as Additional Director at Healthy Life Nutraceuticals Private Limited. The most recent appointment on record is 25 Nov 2025 at Senores Foundation.

The 4 current companies of Anar Swapnil Shah that report revenue have a combined latest revenue of ₹647 Cr: Remus Pharmaceuticals Limited ₹625 Cr (FY 2025); Espee Therapeutics Llp ₹13.65 Cr (FY 2021); Renosen Pharmaceuticals Private Limited ₹7.36 Cr (FY 2025); Aelius Projects Llp ₹45 Lakh (FY 2022).

Anar Swapnil Shah held 4 earlier board appointments: Fifth Gear Fitness Llp (Designated Partner, 08 Jul 2015 to 13 Jun 2024); Senores Pharmaceuticals Limited (Director, 26 Dec 2017 to 03 Nov 2023); Sumer Enterprises Llp (Designated Partner, from 13 Aug 2018); Healthy Life Nutraceuticals Private Limited (Additional Director, from 17 Jul 2014).

The current boards of Anar Swapnil Shah's companies include Arpit Deepakkumar Shah (Remus Pharmaceuticals Limited), Ashutosh Naginbhai Valani (Remus Pharmaceuticals Limited), Balwant Purohit (Remus Pharmaceuticals Limited), Bhavik Rashmikant Shah (Remus Pharmaceuticals Limited), Deval Bakulkumar Patel (Remus Pharmaceuticals Limited), Roma Vinodbhai Shah (Remus Pharmaceuticals Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available